Century Therapeutics (IPSC) Current Leases (2022 - 2025)

Century Therapeutics (IPSC) has 4 years of Current Leases data on file, last reported at $4.9 million in Q2 2025.

• Current Leases for Q2 2025 came in at $4.9 million, up 33.61% year-over-year; the trailing twelve-month figure through Jun 2025 was $4.9 million (up 33.61% YoY), and the FY2024 annual result was $4.9 million, up 221.88% from the prior year.
• Current Leases was little changed at $4.9 million in Q2 2025 per IPSC's latest filing, from $4.9 million in the prior quarter.
• Over five years, Current Leases peaked at $4.9 million in Q2 2025 and troughed at $475000.0 in Q4 2022.
• A 4-year average of $3.1 million and a median of $3.7 million in 2024 frame the typical range for Current Leases.
• The sharpest annual moves came in 2024 and 2025: Current Leases jumped 221.88% in 2024, then soared 33.61% in 2025.
• A 4-year view of Current Leases shows it stood at $475000.0 in 2022, then jumped by 218.53% to $1.5 million in 2023, then jumped by 221.88% to $4.9 million in 2024, then advanced by 0.49% to $4.9 million in 2025.
• Business Quant data shows IPSC's Current Leases at $4.9 million in Q2 2025, $4.9 million in Q1 2025, and $4.9 million in Q4 2024.